These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2134803)

  • 1. [Studies on suppurative lesion and bone distribution of peroral antimicrobial agents (LAPC and TFLX) to experimental infected rabbits].
    Tanaka M; Satoh T
    Shigaku; 1990 Oct; 78(3):527-52. PubMed ID: 2134803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone and suppurative lesion distribution of antimicrobial agents (ampicillin and ofloxacin) in experimental infected rabbits].
    Sugimoto R; Satoh T
    Shigaku; 1989 Apr; 76(7):1527-55. PubMed ID: 2761966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies on bone and suppurative lesion distribution of antimicrobial suppositories (Ampicillin and Ceftizoxime) to experimental infected rabbits].
    Takamatsu K; Satoh T
    Shigaku; 1990 Jun; 78(1):21-47. PubMed ID: 2134957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Penetration into bone and joint tissues of rabbits and in vitro antibacterial activity of tosufloxacin].
    Yamashiro Y; Nunome M; Takahata M; Yasuda T
    Jpn J Antibiot; 1993 Jan; 46(1):31-5. PubMed ID: 8384277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diffusion of tosufloxacin into prostatic tissue.
    Uchibayashi T; Hisazumi H; Kanayama J; Kumano K
    Chemotherapy; 1992; 38(3):150-4. PubMed ID: 1380905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical efficacy of tosufloxacin on the patients with urinary tract infections].
    Yoshida K; Kobayashi N; Saitoh H; Negishi T; Yamada T; Watanabe T; Kawakami S; Tari K; Satake I; Ozawa K
    Hinyokika Kiyo; 1992 Jan; 38(1):129-34. PubMed ID: 1546562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparative clinical study of azithromycin with tosufloxacin tosilate in the treatment of acute odontogenic infection].
    Sasaki J; Kaneko A; Karakida K; Shiiki K; Sakamoto H; Naitoh H; Yamane N; Tomita F; Katoh H; Yoshida H
    Jpn J Antibiot; 1995 Sep; 48(9):1093-118. PubMed ID: 7474331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical studies on tosufloxacin (TFLX) in urology].
    Fukushima S; Moriyama M; Miyamoto H; Hosaka M; Kubota Y; Kinoshita Y; Noguchi K; Shuin T; Noguchi S; Yoshimura S
    Hinyokika Kiyo; 1992 Apr; 38(4):501-6. PubMed ID: 1529827
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gatifloxacine-loaded PLGA and β-tricalcium phosphate composite for treating osteomyelitis.
    Tamazawa G; Ito A; Miyai T; Matsuno T; Kitahara K; Sogo Y; Kimishima K; Satoh T
    Dent Mater J; 2011; 30(3):264-73. PubMed ID: 21597226
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on clinical effects of tosufloxacin (TFLX) and the long-term low dose therapy for the prophylaxis of recurrent urinary tract infection].
    Sakurai M; Sugimura Y; Arima K; Kawamura J; Saitou K; Tajima K; Nakano S; Satani H; Nagano M; Hoshina A
    Hinyokika Kiyo; 1994 Mar; 40(3):279-84. PubMed ID: 8178752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the formation of experimental infected rabbit].
    Satoh T; Heimdahl A
    Shigaku; 1989 Apr; 76(7):1520-6. PubMed ID: 2761965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy of tosufloxacin in children with pneumonia due to Mycoplasma pneumoniae].
    Sakata H
    Jpn J Antibiot; 2012 Jun; 65(3):173-9. PubMed ID: 23173293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo efficacy of trovafloxacin (CP-99,217), a new quinolone, in experimental intra-abdominal abscesses caused by Bacteroides fragilis and Escherichia coli.
    Thadepalli H; Reddy U; Chuah SK; Thadepalli F; Malilay C; Polzer RJ; Hanna N; Esfandiari A; Brown P; Gollapudi S
    Antimicrob Agents Chemother; 1997 Mar; 41(3):583-6. PubMed ID: 9055997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical studies of tosufloxacin on chronic bacterial prostatitis].
    Ikeuchi T; Kawamura N; Suzuki K; Onodera S; Osada T; Hirano A; Satomi Y; Yoshimura S; Yamamoto Y
    Hinyokika Kiyo; 1993 Jul; 39(7):673-8. PubMed ID: 8362691
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Preventive chemotherapy after transurethral prostatectomy: a randomized study].
    Yoshida O; Arai Y; Takeuchi H; Fukuyama T; Hida S; Ikeda T; Okabe T; Kuo SY; Kounami T; Nakagawa T
    Hinyokika Kiyo; 1993 May; 39(5):491-6. PubMed ID: 7686715
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortical bone concentrations of enrofloxacin in dogs.
    Duval JM; Budsberg SC
    Am J Vet Res; 1995 Feb; 56(2):188-92. PubMed ID: 7717584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Concentrations of new quinolone agents in serum and prostate tissue].
    Imai K; Suzuki K; Yamanaka H; Makino T; Yazima H; Takezawa Y; Kitaura K; Shiono A; Sato J; Kato N
    Hinyokika Kiyo; 1994 May; 40(5):401-6. PubMed ID: 7517621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salmonella excretion after cessation of tosufloxacin therapy in acute nontyphoid salmonella enterocolitis.
    Ohnishi K; Kimura K
    Antimicrob Agents Chemother; 2001 Jun; 45(6):1892-3. PubMed ID: 11353646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-abdominal anaerobic infections: bacteriology and therapeutic potential of newer antimicrobial carbapenem, fluoroquinolone, and desfluoroquinolone therapeutic agents.
    Goldstein EJ
    Clin Infect Dis; 2002 Sep; 35(Suppl 1):S106-11. PubMed ID: 12173118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ciprofloxacin on experimental osteomyelitis in the rabbit tibia, induced with a mixed infection of Staphylococcus epidermidis and Bacteroides thetaiotaomicron.
    Mayberry-Carson KJ; Tober-Meyer B; Gill LR; Lambe DW; Hossler FE
    Microbios; 1990; 64(258):49-66. PubMed ID: 2233400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.